What changed for these 31 stocks in Pre Market Session
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market under Nasdaq Rules. The most recent rating by Maxim Group, on January 08, 2020, is a Buy. Curis Inc. (CRIS), a Biotechnology company, dropped about -5.72% at $7.25 in pre-market …
What changed for these 31 stocks in Pre Market Session Read More »